These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 15135474)
1. Integrin expression and survival in human breast cancer. Berry MG; Gui GP; Wells CA; Carpenter R Eur J Surg Oncol; 2004 Jun; 30(5):484-9. PubMed ID: 15135474 [TBL] [Abstract][Full Text] [Related]
2. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers. Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410 [TBL] [Abstract][Full Text] [Related]
3. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064 [TBL] [Abstract][Full Text] [Related]
4. [Molecular-biological markers as prognostic factors in breast cancer of I-IIA stage]. Stepanova EV; Zagrekova EI; Ermilova VD; Turbin AD; Petrovichev NN; Vysotskaia IV; Dbar ZhN; Pashchenko NV; Baryshnikov AIu; Lichinitser MR Arkh Patol; 2003; 65(3):14-8. PubMed ID: 12879604 [TBL] [Abstract][Full Text] [Related]
5. CD24 expression has a prognostic impact in breast carcinoma. Athanassiadou P; Grapsa D; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E Pathol Res Pract; 2009; 205(8):524-33. PubMed ID: 19243896 [TBL] [Abstract][Full Text] [Related]
6. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer. Grönberg M; Fjällskog ML; Jirström K; Janson ET Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021 [TBL] [Abstract][Full Text] [Related]
7. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer. Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693 [TBL] [Abstract][Full Text] [Related]
8. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis. Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI Breast J; 2006; 12(1):37-47. PubMed ID: 16409585 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer. Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475 [TBL] [Abstract][Full Text] [Related]
10. Vimentin expression does not assist in predicting survival in ductal carcinoma of the breast. Heatley MK; Ewings P; Odling Smee W; Maxwell P; Toner PG Pathology; 2002 Jun; 34(3):230-2. PubMed ID: 12109782 [TBL] [Abstract][Full Text] [Related]
11. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695 [TBL] [Abstract][Full Text] [Related]
12. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma. Imai J; Ghazizadeh M; Naito Z; Asano G Anticancer Res; 2001; 21(2B):1327-34. PubMed ID: 11396208 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours. Fiets WE; Bellot FE; Struikmans H; Blankenstein MA; Nortier JW Eur J Surg Oncol; 2005 Mar; 31(2):128-33. PubMed ID: 15698727 [TBL] [Abstract][Full Text] [Related]
15. Lack of prognostic significance of nm23 expression in human primary breast cancer. Göhring UJ; Eustermann I; Becker M; Neuhaus W; Rein DT; Schöndorf T Oncol Rep; 2002; 9(6):1205-8. PubMed ID: 12375020 [TBL] [Abstract][Full Text] [Related]
16. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion]. Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853 [TBL] [Abstract][Full Text] [Related]
18. [Expression and prognostic value of transcriptional factor sp1 in breast cancer]. Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860 [TBL] [Abstract][Full Text] [Related]
19. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast. Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]